AUCKLAND DISTRICT HEALTH BOARD

🇳🇿New Zealand

Country: 🇳🇿New Zealand

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.adhb.govt.nz

Clinical Trials

1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC

Phase 2

Conditions: Clear Cell Renal Cell Carcinoma

Interventions: Drug: Dovitinib

First Posted Date: 2013-02-15

Last Posted Date: 2015-02-03

Lead Sponsor: Auckland District Health Board

Target Recruit Count: 30

Registration Number: NCT01791387

Locations: 🇳🇿
Auckland Hospital, Auckland, New Zealand

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy